Join the Ozempic group to help and get support from people like you.
Ozempic News (Page 6)
No Link Seen Between GLP-1 Receptor Agonist Use and Thyroid Cancer
WEDNESDAY, Jan. 22, 2025 – Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the short term, according to a study published ...
Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic
WEDNESDAY, Jan. 22, 2025 – Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities, federal health officials announced in...
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
TUESDAY, Jan. 21, 2025 – Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even...
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
TUESDAY, Jan. 21, 2025 – Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even...
The New Definition of Obesity
The way obesity is diagnosed needs to become more sophisticated, an international commission has concluded. Using body-mass index (BMI) to tell who is overweight or obese is not reliable, and can...
Perioperative GLP-1 RA Use Reduces Risk for Complications in Patients With Diabetes
MONDAY, Jan. 13, 2025 – For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescription is associated with...
Semaglutide Doubles Risk for Nonarteritic Anterior Ischemic Optic Neuropathy
TUESDAY, Jan. 14, 2025 – Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes, according to a...
Can Elderberry Juice Help You Lose Weight?
FRIDAY, Jan. 10, 2025 – Ozempic? Wegovy? Zepbound? How about elderberry juice? Elderberry juice might help people lose weight and improve their blood sugar control, a new small-scale study says....
Some GLP-1s Achieve More Weight Loss Than Others: Study
WEDNESDAY, Jan. 8, 2025 – Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been approved for that purpose. A new evidence review published ...
GLP-1 RAs Efficacious for Weight Loss in Overweight, Obesity Without Diabetes
TUESDAY, Jan. 7, 2025 – For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published...
How do GLP-1s Boost Weight Loss, Heart Health?
THURSDAY, Jan. 2, 2024 – Weight loss tops many folks’ list of New Years resolutions, and lots of people are turning to cutting-edge weight-loss drugs like Ozempic to help them drop excess pounds. T...
Weight-Loss Drugs, Wily Viruses, Abortion Pill Under Attack: The Top Health Stories of 2024
MONDAY, Dec. 30, 2024 – It was a year in health news that will be hard to forget. As blockbuster weight-loss drugs known as GLP-1s made a sizable dent in the obesity epidemic, study after study...
GLP-1 RAs Reduce Risk for Clinically Important Kidney, CVD Outcomes
FRIDAY, Dec. 6, 2024 – Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) reduce the risk for clinically important kidney and cardiovascular disease outcomes in individuals with type 2 diabetes,...
New Weight-Loss Advance: A Gastric Balloon You Control to Feel Full or Not
TUESDAY, Dec. 3, 2024 – GLP-1 meds are all the rage for weight loss nowadays, but not everyone can safely take the drugs to shed pounds. Invasive weight-loss surgeries can often be a tough sell,...
American Heart Association, Nov. 16-18
The annual meeting of the American Heart Association was held this year from Nov. 16 to 18 in Chicago, drawing attendees from around the world, including cardiovascular specialists, surgeons, and n...
Further information
Related condition support groups
Weight Loss (Obesity / Overweight), Chronic Kidney Disease, Cardiovascular Risk Reduction, Diabetes, Type 2